Analysts Offer Predictions for INSP Q3 Earnings

Key Points

• Inspire Medical Systems is expected to earn $0.25 per share for Q3 2025, according to analysts at KeyCorp, who also estimate full-year earnings of $2.16 per share.
• The company reported a quarterly EPS of $0.45, surpassing expectations of $0.22, with a revenue of $217.09 million, a 10.8% increase year-over-year.
• Recent analyst ratings show a diverse outlook on the stock, with target prices ranging from $101.00 to $236.00 and an average rating of "Moderate Buy" among 14 analysts.

Inspire Medical Systems, Inc. (NYSE:INSP - Free Report) - Stock analysts at KeyCorp issued their Q3 2025 earnings estimates for shares of Inspire Medical Systems in a research note issued to investors on Monday, August 4th. KeyCorp analyst B. Fishbin expects that the company will earn $0.25 per share for the quarter. KeyCorp currently has a "Sector Weight" rating on the stock. The consensus estimate for Inspire Medical Systems' current full-year earnings is $2.16 per share. KeyCorp also issued estimates for Inspire Medical Systems' Q4 2025 earnings at $0.84 EPS, FY2025 earnings at $1.64 EPS and FY2026 earnings at $1.69 EPS.

Inspire Medical Systems (NYSE:INSP - Get Free Report) last released its earnings results on Monday, August 4th. The company reported $0.45 EPS for the quarter, beating the consensus estimate of $0.22 by $0.23. Inspire Medical Systems had a net margin of 6.17% and a return on equity of 10.38%. The company had revenue of $217.09 million for the quarter, compared to analyst estimates of $214.50 million. During the same quarter last year, the firm earned $0.32 EPS. The firm's quarterly revenue was up 10.8% compared to the same quarter last year.

INSP has been the topic of a number of other research reports. Robert W. Baird raised their price target on shares of Inspire Medical Systems from $230.00 to $236.00 and gave the stock an "outperform" rating in a report on Tuesday, May 6th. UBS Group set a $230.00 target price on shares of Inspire Medical Systems and gave the stock a "buy" rating in a research report on Tuesday. Royal Bank Of Canada dropped their target price on shares of Inspire Medical Systems from $215.00 to $180.00 and set an "outperform" rating for the company in a research report on Tuesday. Truist Financial reaffirmed a "hold" rating and issued a $125.00 target price (down from $190.00) on shares of Inspire Medical Systems in a research report on Tuesday. Finally, Wells Fargo & Company dropped their target price on shares of Inspire Medical Systems from $174.00 to $101.00 and set an "equal weight" rating for the company in a research report on Tuesday. Seven analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $173.31.

Inspire Medical Systems Stock Down 10.7%

Shares of Inspire Medical Systems stock opened at $78.54 on Thursday. The firm has a market cap of $2.32 billion, a PE ratio of 45.40, a price-to-earnings-growth ratio of 6.76 and a beta of 1.22. Inspire Medical Systems has a 12-month low of $73.92 and a 12-month high of $225.00. The company's fifty day simple moving average is $130.39 and its two-hundred day simple moving average is $153.83.

Hedge Funds Weigh In On Inspire Medical Systems

Institutional investors have recently bought and sold shares of the business. True Wealth Design LLC lifted its holdings in shares of Inspire Medical Systems by 39.0% in the 4th quarter. True Wealth Design LLC now owns 196 shares of the company's stock worth $36,000 after acquiring an additional 55 shares during the last quarter. Captrust Financial Advisors increased its stake in Inspire Medical Systems by 2.0% in the 4th quarter. Captrust Financial Advisors now owns 3,034 shares of the company's stock worth $562,000 after buying an additional 59 shares during the period. MML Investors Services LLC increased its stake in Inspire Medical Systems by 0.9% in the 4th quarter. MML Investors Services LLC now owns 7,941 shares of the company's stock worth $1,472,000 after buying an additional 67 shares during the period. Mariner LLC increased its stake in Inspire Medical Systems by 1.6% in the 4th quarter. Mariner LLC now owns 4,837 shares of the company's stock worth $897,000 after buying an additional 77 shares during the period. Finally, Farther Finance Advisors LLC increased its stake in Inspire Medical Systems by 14.6% in the 2nd quarter. Farther Finance Advisors LLC now owns 603 shares of the company's stock worth $78,000 after buying an additional 77 shares during the period. Institutional investors own 94.91% of the company's stock.

About Inspire Medical Systems

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.